SCHEMBL7144401

SCHEMBL7144401

Nc1cccc2nc(-c3ccccc3)nn12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 8/20 0.53
NUDT1 P36639 1/20 0.51
AHR P35869 1/20 0.50
ADORA1 P30542 5/20 0.46
ADORA2A P29274 5/20 0.46
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
POLB P06746 1/20 0.42
ADORA2B P29275 1/20 0.42
CYP11B2 P19099 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7151749 0.82 ALDH1A1 (0.49) ADORA3ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL7423524 0.79 ALDH1A1 (0.53) ADORA3ADORA1ADORA2AALDH1A1SMN1; SMN2
SCHEMBL7145308 0.79 MAP3K5 (0.43) ADORA3NUDT1AHRADORA1ADORA2A
SCHEMBL30676207 0.79 AHR (0.78) ADORA3NUDT1AHRADORA1ADORA2A
SCHEMBL31722871 0.77 ADORA3 (0.51) ADORA3NUDT1AHRADORA1ADORA2A
SCHEMBL7434291 0.77 ALDH1A1 (0.57) ADORA3AHRADORA1ADORA2AALDH1A1
SCHEMBL7148143 0.77 ADORA2A (0.54) ADORA1ADORA2AALDH1A1SMN1; SMN2HTT
SCHEMBL7709122 0.77 MAOA (0.47) ADORA3ADORA1ADORA2AALDH1A1SMN1; SMN2
SCHEMBL24656050 0.75 NUDT1 (0.59) NUDT1AHRALDH1A1SMN1; SMN2NPC1
SCHEMBL7703064 0.75 ALDH1A1 (0.45) ADORA3ADORA1ADORA2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506772-B1 Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. HOFFMANN-LA ROCHE INC. 2003-01-14 US disclosed